FundingPayments

Correlia Biosystems: Raises $7M in Series A Funding

  • Correlia Biosystems, a Berkeley, CA-based life science startup, closed a $7m Series A financing round
  • The round led by Neotribe Ventures, joined by Cota Capital, the Regents of the University of California, and others
  • NeoTribe Ventures joins Correlia’s board of directors as part of the financing
  • The company also intends to use the funds for the commercial launch of its immunoassay platform
  • This will also the first instrument planned in their larger suite of proteomics tools focused on highly efficient and automated protein measurements
  • Correlia is launching a product to miniaturize Elisa, a quantitative test for proteins and antibodies widely used in drug development, vaccine development, and diagnostics
Previous article
Shinhan Bank: Enhanced Cooperations with partners in diversified fields
Next article
Alliance Data: Completes Acquisition of Bread
Steve Sam
Steve Sam
Steve Sam is a financial reporter, analyst, and commentator with a strong focus on banking technology, digital payments, and the future of financial services.

You May Also Like

FinTech

New York State Mandates Stores to Accept Cash Payments

New legislation aims to protect cash transactions across the state.Highlights: New law requires New York stores to accept...
FinTech

PRA Issues £2 Million Penalty to Bank of London for Integrity Failures

Regulatory body penalizes the bank due to integrity shortcomings.Highlights: PRA fines Bank of London £2 million for integrity...
FinTech

HSBC Appoints First Chief AI Officer, Strengthening AI Leadership

The bank aims to enhance its AI strategy and innovation.Highlights: HSBC names its first Chief AI Officer to...
FinTech

Revolut Reports Surging Profits as Growth Accelerates

The financial technology firm sees significant profit increases in its latest report.Highlights: Revolut's profits surged significantly in the...